Why Should Biopharma Consider An End-to-End CDMO Partnership

Timelines for drug development and manufacturing have become shorter, with processes that previously took two years - for example moving from cell bank construction to GMP manufacturing - decreasing to 18 months or even in a year in some scenarios.